ReviewViruses2018
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.
Jennifer A Pickens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it
ReviewViruses2018
Jennifer A Pickens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.